Lecithin in the treatment of Gilles de la Tourette's syndrome.
Five patients with Tourette's syndrome were administered a mean dose of 512 mg/kg per day of oral lecithin. None of the patients exhibited sustained clinical improvement in symptom severity. No significant changes in serum prolactin or growth hormone were observed during lecithin administration.
D000284:Administration, Oral; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood; D005879:Tourette Syndrome / Q000097:blood / Q000188:drug therapy* / Q000523:psychology
D010713:Phosphatidylcholines; D011388:Prolactin; D013006:Growth Hormone